Strategic partnerships Institut Imagine actively collaborates with European and national research and patient advocacy groups (EURORDIS Working Group, TEDDY Network, AFM-Téléthon, AP-HP), indicating openness to joint programs, funding opportunities, and co-developed clinical trials.

Clinical scale With a large translational research footprint housed in a 19,000 sqm facility at Necker Children’s Hospital and substantial patient cohorts, there is strong potential for collaborations offering scaling capabilities, data sharing, and access to well-characterized patient populations.

Tech enablement Adoption of diverse tech tools (Docker, PostgreSQL, Tableau, Joomla, Usercentrics, Trello, Mailchimp) suggests readiness for data management, analytics, regulated digital platforms, and workflow automation that can be matched with enterprise software and cloud services.

Funding alignment Recent and ongoing partnerships with AFM-Téléthon, AP-HP, and other funders indicate a favorable funding environment for gene therapy and vector production initiatives, presenting opportunities for technology transfer, GMP-grade manufacturing support, and research outsourcing.

Public engagement Launch of RareSim and educational initiatives signals a demand for outreach, training, and scalable patient-education platforms, creating sales opportunities for digital education tools, simulation software, and knowledge dissemination services.